Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Projected 2018 revenue for top 10 drugs approved U.S. 2013

This statistic displays the projected 2018 revenue for top 10 drugs approved in the U.S. in 2013. Tivicay, approved on August 12, 2013, and developed by GlaxoSmithKline, is estimated to generate 2.13 billion U.S. dollars in annual revenue in 2018. Pharmaceutical and biotechnology companies experienced widespread growth worldwide with the United States garnering the largest growth.

Projected 2018 revenue for top 10 drugs approved in the U.S. in 2013

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2014

Region

United States

Survey time period

2013 and 2014

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Norway "

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.